Trial Library
Trial Library is an AI-native platform that connects community oncology providers, biopharma sponsors, and payers to accelerate clinical trial enrollment and patient navigation, serving 840+ clinics and 3,000+ providers in the United States.
- Company typePrivate
- Founded2022
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Trial Library does
Trial Library, Inc. is a San Francisco-based, venture-backed software company spun out of UCSF in 2022 by physician-founder Dr. Hala Borno. It operates an AI-native platform that integrates oncology clinical trials into routine community care by activating oncologists, identifying eligible patients at the point of care through EHR-integrated alerts with match-confidence scoring, and navigating patients through the trial lifecycle via a combination of conversational AI, internal referral optimization, and human "Ally Navigators" who address logistical barriers (transportation, language, scheduling, food). The platform serves three buyer cohorts: biopharma sponsors seeking faster, more representative enrollment; community oncology providers and health systems who gain pre-screening reimbursement, trial search, and referral tooling at no cost; and payers and self-insured employers integrating trial access as a covered member benefit. Named partners and customers include Johnson & Johnson Innovative Medicine, Guardant Health, Texas Oncology, American Oncology Network, The Oncology Institute, Trinity Health, MemorialCare, and AccessHope, with the network reported at 840+ clinics and 3,000+ providers as of May 2026.
Trial Library firmographics
Firmographics- Name
- Trial Library
- Legal name
- Trial Library, Inc.
- Website
- https://triallibrary.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Trial Library is an AI-native platform that connects community oncology providers, biopharma sponsors, and payers to accelerate clinical trial enrollment and patient navigation, serving 840+ clinics and 3,000+ providers in the United States.
- Ownership category
- akta.pro rank
Trial Library industry classification
Industry- Product category
- Clinical Trial Technology
- NAICS
- Other Scientific and Technical Consulting Services (541690), Computer Systems Design and Related Services (54151)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industries
- Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ), Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials) (HLAAANAI)
Keywords
Where Trial Library is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Trial Library business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Biopharma Sponsor Services: Trial Library partners with biopharmaceutical companies (sponsors) to accelerate patient recruitment and enrollment for clinical trials. Sponsors pay for access to Trial Library's network of providers and pre-qualified patients, enabling faster enrollment and better representation in trials.
- Payer & Employer Partnerships: Trial Library is the first platform to unlock the payer market for clinical trial access, aligning incentives across patients, providers, payers, and life-science partners. Revenue comes from integrating clinical trial access into member benefits for health plans and self-insured employers.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels4 records
Trial Library product offering
Product offeringCore offering
Trial Library operates an AI-native platform that integrates clinical trials into routine care by activating healthcare providers, identifying eligible patients through conversational search and EHR-integrated alerts, and navigating patients through the trial lifecycle. The platform connects biopharma sponsors, community oncology providers, and payers/employers into a coordinated research ecosystem, providing pre-screening services, intelligent navigation, and a rapidly growing network of 840+ clinics and 3,000+ providers.
Product overview
Trial Library is an AI-native platform offering a unified portfolio of clinical trial access solutions. The core Trial Library Platform integrates provider activation, patient-trial matching, and longitudinal navigation. Supporting modules include Health Provider Activation (intelligent pre-screening and referrals), Internal Referral Optimization (site augmentation for population analysis), Intelligent Navigation OS (AI-powered barrier resolution), and Conversational Trial Search (plain-language trial querying). The company also offers dedicated solutions for sponsors (provider/patient access), providers (rapid referral in under a minute), and payers/employers (benefit integration). Services include the Ally Navigation Program (human navigators addressing transportation, food, language, and scheduling barriers) and Clinical Trial Pre-screening Services (remote or in-person chart review by Clinical Data Coordinators). The platform currently operates across 840+ clinics and 3,000+ providers nationwide, serving biopharma sponsors, community oncologists, health plans, and self-insured employers.
Differentiator
Problem solved
Functional benefit
Products and services
- Trial Library Platform
- Conversational AI Trial Search
- For Sponsors
- For Providers
- For Payers & Employers
- Ally Navigation Program
- Clinical Trial Pre-screening Services
Quantifiable outcome
- 89% provider satisfaction rate with centralized trial search (published study)
- +3 more outcomes
Companies that use Trial Library
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles3 records
Trial Library technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability6 records
Feature4 records
Trial Library partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and strategic.
- Guardant HealthcoreStrategic collaboration announced December 2025 to increase access to cancer clinical trials across the United States. Combines Guardant's precision oncology diagnostics and genomic data (from over 1 million patients tested) with Trial Library's AI-powered patient matching and navigation platform. Partnership aims to address the gap between genomic discovery and clinical trial participation, particularly in rural communities.
- Johnson & Johnson Innovative MedicinecoreLeading global biopharmaceutical manufacturer partnering with Trial Library to accelerate R&D and patient enrollment. Partnership is part of Trial Library's growing ecosystem of pharma sponsors.
- The Oncology InstitutecorePartnership with The Oncology Institute of Hope & Innovation to expand patient access to clinical trials. The Oncology Institute is part of Trial Library's rapidly expanding provider network.
- American Oncology NetworkcoreStrategic partnership with American Oncology Network (AON) to expand patient access to clinical trials across the network's oncology practices.
- Texas OncologycorePartnership with Texas Oncology to expand patient access to clinical trials, providing pre-screening reimbursement and navigation support to the practice.
- AccessHopestrategicAccessHope launched a new service utilizing technology from Trial Library to help more cancer patients enroll in clinical trials. Service targets community oncologists and aims to expand access to innovative treatments for socially vulnerable communities. Trial Library provides the technology foundation for patient-trial matching.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
Trial Library competitors and assessment
Company assessmentDirect peers
- TrialX: TrialX offers a patient-trial matching platform and clinical research exchange used by sponsors, providers, and patients. It targets the same clinical trial access problem with a similar multi-stakeholder approach, making it a comparable direct peer.
- H1: H1 provides a global platform connecting biopharma with clinical trial sites, investigators, and patient populations through data analytics. It overlaps with Trial Library's provider activation and site intelligence layer for biopharma sponsors.
- Deep 6 AI: Deep 6 AI uses AI to mine EHR data for patient-trial matching, focused on accelerating oncology and rare disease enrollment. It competes directly with Trial Library in AI-driven site activation and patient identification for community-based trials.
- Mendel: Mendel applies large language models to structured and unstructured clinical data for patient-trial matching. It targets similar biopharma sponsors and health systems for cohort identification, making it a closely overlapping competitor in clinical trial enablement.
- Massive Bio: Massive Bio operates an AI-enabled oncology clinical trial enrollment platform that connects patients and providers to trials, with a strong emphasis on community oncology and minority representation. It is one of Trial Library's closest direct competitors in oncology enrollment enablement.
- Verana Health: Verana Health turns specialty clinical data into real-world evidence and trial-ready cohorts. Trial Library's Chief Product Officer Karim Damji was a founding team member, indicating deep operational overlap in life-sciences data and clinical trial enablement.
Emerging players
- Science 37: Science 37 pioneered decentralized and hybrid clinical trial operations, with patient recruitment and remote participation capabilities. It is comparable on the decentralized/community trial thesis but operates with a fuller operational stack than Trial Library's tech-led model.
- Medable: Medable provides a decentralized clinical trial platform for eCOA, eConsent, and remote patient engagement. While its software targets trial sponsors and sites similarly, it focuses on enabling tech infrastructure rather than community oncology provider activation.
Broad incumbents
- Tempus AI: Tempus combines precision oncology diagnostics (similar to Trial Library's Guardant integration) with a clinical trial matching layer (TIME program). It serves overlapping biopharma sponsors and offers broader data, but is a much larger, broader platform rather than a focused community-trial network.
- Flatiron Health: Flatiron Health (acquired by Roche) offers oncology-specific EHR, real-world evidence, and clinical trial enablement. It serves biopharma sponsors with similar use cases but operates at much greater scale and as part of a wider oncology data portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Trial Library social profiles
Digital presenceTrial Library compliance and trust
Trust signalCompliance2 records
Trial Library financial estimates
Financial estimateRevenue estimate
Valuation estimate
Trial Library leadership team
Management profileNumber of profiles
Profiles10 records
Trial Library funding detail
Funding detailFunding overview
Funding rounds3 records
Investors11 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Trial Library M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Trial Library
What does Trial Library do?
Trial Library operates an AI-native platform that integrates clinical trials into routine care by activating healthcare providers, identifying eligible patients through conversational search and EHR-integrated alerts, and navigating patients through the trial lifecycle. The platform connects biopharma sponsors, community oncology providers, and payers/employers into a coordinated research ecosystem, providing pre-screening services, intelligent navigation, and a rapidly growing network of 840+ clinics and 3,000+ providers.
Is Trial Library a public or private company?
Trial Library is a private company. It is classified as venture growth investor backed and is currently operating.
When was Trial Library founded?
Trial Library was founded in 2022. It employs 11 to 50 people.
Where is Trial Library based?
Trial Library is headquartered in San Francisco, United States, in the North America region.
How does Trial Library make money?
Two revenue lines are on record. Biopharma Sponsor Services are the primary driver. The others are payer & Employer Partnerships.
Who are Trial Library's main competitors?
Direct peers on record are TrialX, H1, Deep 6 AI, Mendel, Massive Bio and Verana Health. Emerging players are Science 37 and Medable. Broad incumbents are Tempus AI and Flatiron Health.
Does Trial Library have an API?
No public API is recorded for Trial Library.
What industry is Trial Library in?
Trial Library's product category is Clinical Trial Technology. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLACAOAJ, Site & Investigator Platforms (Site Payments, Feasibility, Activation). Its NAICS code is 541690 and its SIC code is 8000.